Amyotrophic Lateral Sclerosis: Review
暂无分享,去创建一个
[1] Angela M. Malek,et al. The epidemiology of amyotrophic lateral sclerosis. , 2016, Handbook of clinical neurology.
[2] Robert H. Brown,et al. Emerging mechanisms of molecular pathology in ALS. , 2015, The Journal of clinical investigation.
[3] G. Comi,et al. TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations , 2015, Journal of Neurology.
[4] Brittany N. Lasseigne,et al. Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways , 2015, Science.
[5] T. Wieland,et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia , 2015, Nature Neuroscience.
[6] Robert H. Brown,et al. Novel mutations support a role for Profilin 1 in the pathogenesis of ALS , 2015, Neurobiology of Aging.
[7] Johann S. Hawe,et al. Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression , 2014, Nature Biotechnology.
[8] G. Rouleau,et al. Dissection of genetic factors associated with amyotrophic lateral sclerosis , 2014, Experimental Neurology.
[9] J. Ravits,et al. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis , 2014, Experimental Neurology.
[10] N. Cashman,et al. Exosome-dependent and independent mechanisms are involved in prion-like transmission of propagated Cu/Zn superoxide dismutase misfolding , 2014, Prion.
[11] Nazem Atassi,et al. Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS) , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[12] P. Preux,et al. Epidemiological evidence that physical activity is not a risk factor for ALS , 2014, European Journal of Epidemiology.
[13] E. Beghi,et al. Physical activity and amyotrophic lateral sclerosis: A European population‐based case–control study , 2014, Annals of neurology.
[14] Elaine Niven,et al. Screening for cognition and behaviour changes in ALS , 2014, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[15] A. Hill,et al. Intercellular propagated misfolding of wild-type Cu/Zn superoxide dismutase occurs via exosome-dependent and -independent mechanisms , 2014, Proceedings of the National Academy of Sciences.
[16] D. Kerr,et al. Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database , 2013, BMC Neurology.
[17] A. Al-Chalabi,et al. The epidemiology of ALS: a conspiracy of genes, environment and time , 2013, Nature Reviews Neurology.
[18] Robert H. Brown,et al. Amyotrophic lateral sclerosis: Problems and prospects , 2013, Annals of neurology.
[19] D. Levy,et al. Body mass index (BMI) as predictor of ALSFRS-R score decline in ALS patients , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[20] M. Thun,et al. Premorbid body mass index and risk of amyotrophic lateral sclerosis , 2013, Amyotrophic lateral sclerosis & frontotemporal degeneration.
[21] Michael Benatar,et al. Prion-like domain mutations in hnRNPs cause multisystem proteinopathy and ALS , 2013, Nature.
[22] D. Goldstein,et al. Novel mutation in VCP gene causes atypical amyotrophic lateral sclerosis , 2012, Neurology.
[23] P. Lagergren,et al. Patients’ perspectives of living with a percutaneous endoscopic gastrostomy (PEG) , 2012, BMC Gastroenterology.
[24] A. Goris,et al. EPHA4 is a disease modifier of amyotrophic lateral sclerosis in animal models and in humans , 2012, Nature Medicine.
[25] R. Spataro,et al. Factors affecting the diagnostic delay in amyotrophic lateral sclerosis , 2012, Clinical Neurology and Neurosurgery.
[26] Y. Kuroiwa,et al. Reduction rate of body mass index predicts prognosis for survival in amyotrophic lateral sclerosis: A multicenter study in Japan , 2012, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[27] S. Pereson,et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study , 2012, The Lancet Neurology.
[28] A. Ludolph,et al. Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[29] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[30] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[31] R. Ruthazer,et al. Shoulder Pain in Amyotrophic Lateral Sclerosis , 2011, Journal of clinical neuromuscular disease.
[32] O. Hardiman,et al. The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[33] D. Schoenfeld,et al. Advanced statistical methods to study the effects of gastric tube and non-invasive ventilation on functional decline and survival in amyotrophic lateral sclerosis , 2011, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[34] I. Aydogdu,et al. Dysfunction of bulbar central pattern generator in ALS patients with dysphagia during sequential deglutition , 2011, Clinical Neurophysiology.
[35] Leonard H van den Berg,et al. Population based epidemiology of amyotrophic lateral sclerosis using capture–recapture methodology , 2011, Journal of Neurology, Neurosurgery & Psychiatry.
[36] R. Spataro,et al. Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: Effect on survival , 2011, Journal of the Neurological Sciences.
[37] O. Hardiman,et al. Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia , 2011, Neurology.
[38] S. Messina,et al. The diagnosis of Amyotrophic lateral sclerosis in 2010. , 2011, Archives italiennes de biologie.
[39] Patrizia Sola,et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS , 2011, Neuron.
[40] P. Preux,et al. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[41] Jeffrey Cummings,et al. Dextromethorphan Plus Ultra Low‐Dose Quinidine Reduces Pseudobulbar Affect , 2010, Annals of neurology.
[42] Brandon E Gavett,et al. TDP-43 Proteinopathy and Motor Neuron Disease in Chronic Traumatic Encephalopathy , 2010, Journal of neuropathology and experimental neurology.
[43] A. Al-Chalabi,et al. Nutritional factors associated with survival following enteral tube feeding in patients with motor neurone disease. , 2010, Journal of human nutrition and dietetics : the official journal of the British Dietetic Association.
[44] C. Shaw,et al. Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase , 2010, Proceedings of the National Academy of Sciences.
[45] L. Wilkins. Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology , 2010, Neurology.
[46] M. Goldacre,et al. Head and other physical trauma requiring hospitalisation is not a significant risk factor in the development of ALS , 2010, Journal of the Neurological Sciences.
[47] M. York,et al. Detecting frontotemporal dysfunction in ALS: Utility of the ALS Cognitive Behavioral Screen (ALS-CBS™) , 2010, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[48] C. Armon. Smoking may be considered an established risk factor for sporadic ALS , 2009, Neurology.
[49] H. Mitsumoto,et al. Subcommittee of the American Academy of Neurology Evidence-based Review) : Report of the Quality Standards Management, and Cognitive/behavioral Impairment (an Amyotrophic Lateral Sclerosis: Multidisciplinary Care, Symptom Practice Parameter Update: the Care of the Patient With , 2022 .
[50] A. L. La Spada,et al. ALS motor phenotype heterogeneity, focality, and spread , 2009, Neurology.
[51] A. Al-Chalabi,et al. Natural history and clinical features of the flail arm and flail leg ALS variants , 2009, Neurology.
[52] J L Haines,et al. Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .
[53] J. Friedman. PRACTICE PARAMETER: ASSESSING PATIENTS IN A NEUROLOGY PRACTICE FOR RISK OF FALLS (AN EVIDENCE-BASED REVIEW): REPORT OF THE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY , 2009, Neurology.
[54] E. Beghi,et al. Prognostic factors in ALS: A critical review , 2009, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[55] P. Cintas,et al. Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study , 2008, European journal of neurology.
[56] E. Beghi,et al. Predictors of long survival in amyotrophic lateral sclerosis: A population-based study , 2008, Journal of the Neurological Sciences.
[57] H. Guchelaar,et al. An Association Study of Riluzole Serum Concentration and Survival and Disease Progression in Patients With ALS , 2008, Clinical pharmacology and therapeutics.
[58] B. Kaspar,et al. Gene-targeted therapies for the central nervous system. , 2008, Archives of neurology.
[59] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[60] M. Swash,et al. Electrodiagnostic criteria for diagnosis of ALS , 2008, Clinical Neurophysiology.
[61] E. Beghi,et al. Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues , 2007, Journal of Neurology, Neurosurgery, and Psychiatry.
[62] E. Abel. Football Increases the Risk for Lou Gehrig's Disease, Amyotrophic Lateral Sclerosis , 2007, Perceptual and motor skills.
[63] Roland G Henry,et al. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.
[64] R. Henry,et al. Establishing subtypes of the continuum of frontal lobe impairment in amyotrophic lateral sclerosis. , 2007, Archives of neurology.
[65] H. Akiyama,et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.
[66] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[67] S. Ennis,et al. ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis , 2006, Nature Genetics.
[68] P. Shaw,et al. Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial , 2006, The Lancet Neurology.
[69] A. Al-Chalabi,et al. Survival of patients with ALS following institution of enteral feeding is related to pre‐procedure oximetry: A retrospective review of 98 patients in a single centre , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.
[70] P. Andersen,et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives , 2005, European journal of neurology.
[71] L. H. van den Berg,et al. Multidisciplinary ALS care improves quality of life in patients with ALS , 2005, Neurology.
[72] P. Preux,et al. Complications and survival following radiologically and endoscopically-guided gastrostomy in patients with amyotrophic lateral sclerosis , 2005, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[73] A. Al-Chalabi,et al. Trouble on the pitch: are professional football players at increased risk of developing amyotrophic lateral sclerosis? , 2005, Brain : a journal of neurology.
[74] A. Chiò,et al. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. , 2005, Brain : a journal of neurology.
[75] M. Thun,et al. Prospective study of military service and mortality from ALS , 2005, Neurology.
[76] Miller Rg,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND) , 2003 .
[77] R. Sufit,et al. Percutaneous endoscopic gastrostomy (PEG) in patients with ALS and bulbar dysfunction , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[78] O. Hardiman,et al. Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000 , 2003, Journal of neurology, neurosurgery, and psychiatry.
[79] A. Al-Chalabi,et al. Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002 , 2003, Journal of neurology, neurosurgery, and psychiatry.
[80] R. Miller,et al. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). , 2003, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[81] V. Meininger,et al. A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis , 2002, Journal of Neurology.
[82] M. Tavakoli. Disease progression in amyotrophic lateral sclerosis. Identifying the cost-utility of riluzole by disease stage. , 2002, The European journal of health economics : HEPAC : health economics in prevention and care.
[83] P. Worms. The epidemiology of motor neuron diseases: a review of recent studies , 2001, Journal of the Neurological Sciences.
[84] O. Hardiman,et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study. , 2000, Archives of neurology.
[85] M. Swash,et al. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[86] P. Preux,et al. Nutritional assessment and survival in ALS patients. , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.
[87] J. Cedarbaum,et al. A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials , 1999, Journal of the Neurological Sciences.
[88] S. Rudnicki. Factors influencing a patient's decision regarding riluzole: an early experience , 1997, Journal of the Neurological Sciences.
[89] S. Durrleman,et al. A confirmatory dose-ranging study of riluzole in ALS , 1996, Neurology.
[90] P. Leigh,et al. Dose-ranging study of riluzole in amyotrophic lateral sclerosis , 1996, The Lancet.
[91] M. Luís,et al. Respiratory assistance with a non-invasive ventilator (Bipap) in MND/ALS patients: Survival rates in a controlled trial , 1995, Journal of the Neurological Sciences.
[92] P. Andersen,et al. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase , 1995, Nature Genetics.
[93] V. Meininger,et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. , 1994, The New England journal of medicine.
[94] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[95] A. Steck,et al. Diagnosis of amyotrophic lateral sclerosis , 1991, Annals of neurology.